SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lene Ringholm, Julie Agner Damm, Marianne Vestgaard, Peter Damm, Elisabeth R. Mathiesen, Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding, Current Diabetes Reports, 2016, 16, 2

    CrossRef

  2. 2
    O. Pourrat, Conduite à tenir chez une hypertendue artérielle chronique pendant la grossesse et le postpartum, La Revue de Médecine Interne, 2015, 36, 3, 191

    CrossRef

  3. 3
    Fernanda Sales Luiz Vianna, Lavinia Schüler-Faccini, Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  4. 4
    Angela Elena Vinturache, Francine Gabriel Smith, Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects, Vascular Pharmacology, 2014, 63, 3, 145

    CrossRef

  5. 5
    Titia P.E. Ruys, Aldo Maggioni, Mark R. Johnson, Karen Sliwa, Luigi Tavazzi, Markus Schwerzmann, Petros Nihoyannopoulos, Mirta Kozelj, Ariane Marelli, Uri Elkayam, Roger Hall, Jolien W. Roos-Hesselink, Cardiac medication during pregnancy, data from the ROPAC, International Journal of Cardiology, 2014, 177, 1, 124

    CrossRef

  6. 6
    Seema R. Lalani, John W. Belmont, Genetic basis of congenital cardiovascular malformations, European Journal of Medical Genetics, 2014, 57, 8, 402

    CrossRef

  7. 7
    April K. Marrone, Jacqueline Ho, MicroRNAs: potential regulators of renal development genes that contribute to CAKUT, Pediatric Nephrology, 2014, 29, 4, 565

    CrossRef

  8. 8
    Ihor V. Yosypiv, Renin–angiotensin system in ureteric bud branching morphogenesis: implications for kidney disease, Pediatric Nephrology, 2014, 29, 4, 609

    CrossRef

  9. 9
    Marie Darby, James N Martin, Babbette LaMarca, A complicated role for the renin–angiotensin system during pregnancy: highlighting the importance of drug discovery, Expert Opinion on Drug Safety, 2013, 12, 6, 857

    CrossRef

  10. 10
    Catherine Vasilakis-Scaramozza, Ann Aschengrau, Howard J. Cabral, Susan S. Jick, Antihypertensive Drugs and the Risk of Congenital Anomalies, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 5
  11. 11
    Diego N. Capelari, Susana I. Sánchez, Hugo H. Ortega, Gladys M. Ciuffo, Lucia B. Fuentes, Effects of maternal captopril treatment during late pregnancy on neonatal lung development in rats, Regulatory Peptides, 2012, 177, 1-3, 97

    CrossRef

  12. 12
    Janine E. Polifka, Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 8
  13. 13
    Aisha Lateef, Michelle Petri, Management of pregnancy in systemic lupus erythematosus, Nature Reviews Rheumatology, 2012, 8, 12, 710

    CrossRef

  14. 14
    Lene Ringholm, Elisabeth R. Mathiesen, Louise Kelstrup, Peter Damm, Managing type 1 diabetes mellitus in pregnancy—from planning to breastfeeding, Nature Reviews Endocrinology, 2012, 8, 11, 659

    CrossRef

  15. 15
    Michael Levine, Ayrn D. O'Connor, Obstetric Toxicology, Emergency Medicine Clinics of North America, 2012, 30, 4, 977

    CrossRef

  16. 16
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  17. 17
    Renfang Song, Ihor V. Yosypiv, (Pro)renin Receptor in Kidney Development and Disease, International Journal of Nephrology, 2011, 2011, 1

    CrossRef

  18. 18
    Vellore J Karthikeyan, Robin E Ferner, Sabah Baghdadi, Deirdre A Lane, Gregory YH Lip, D Gareth Beevers, Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies, Journal of Hypertension, 2011, 29, 2, 396

    CrossRef

  19. 19
    Renfang Song, Ihor V. Yosypiv, Genetics of congenital anomalies of the kidney and urinary tract, Pediatric Nephrology, 2011, 26, 3, 353

    CrossRef

  20. 20
    Sarah Običan, Anthony R. Scialli, Teratogenic exposures, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011, 157, 3
  21. 21
    A. Walfisch, A. Al-maawali, M. E. Moretti, C. Nickel, G. Koren, Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers, Journal of Obstetrics & Gynaecology, 2011, 31, 6, 465

    CrossRef

  22. 22
    Carl A. Laskin, Karen A. Spitzer, Christine A. Clark, Systemic Lupus Erythematosus, 2011,

    CrossRef

  23. 23
    Susan L. Makris, Developmental and Reproductive Toxicology: A Practical Approach, 2011,

    CrossRef

  24. 24
    Jasmine Grewal, Samuel C. Siu, Heather J. Ross, Jack M. Colman, Candice K. Silversides, Reply, Journal of the American College of Cardiology, 2010, 55, 20, 2291

    CrossRef

  25. 25
    Tinuade A. Ogunlesi, Folasade Adekanmbi, Evaluating and managing neonatal acute renal failure in a resource-poor setting, The Indian Journal of Pediatrics, 2009, 76, 3, 293

    CrossRef

  26. 26
    Ihor V. Yosypiv, Renin–angiotensin system–growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis, Pediatric Nephrology, 2009, 24, 6, 1113

    CrossRef

  27. 27
    William O. Cooper, Clinical Implications of Increased Congenital Malformations After First Trimester Exposures to Angiotensin-Converting Enzyme Inhibitors, The Journal of Cardiovascular Nursing, 2008, 23, 1, 20

    CrossRef

  28. 28
    Michael E. Bowen, Wayne A. Ray, Patrick G. Arbogast, Hua Ding, William O. Cooper, Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy, American Journal of Obstetrics and Gynecology, 2008, 198, 3, 291.e1

    CrossRef

  29. 29
    Susan E. Andrade, Marsha A. Raebel, Jeffrey Brown, Kimberly Lane, James Livingston, Denise Boudreau, Sharon J. Rolnick, Douglas Roblin, David H. Smith, Gerald J. Dal Pan, Pamela E. Scott, Richard Platt, Outpatient use of cardiovascular drugs during pregnancy, Pharmacoepidemiology and Drug Safety, 2008, 17, 3
  30. 30
    Salim Kees, Eyal Schiff, Fetal Cardiology, 2008,

    CrossRef

  31. 31
    Jeremy JN Oats, Textbook of Periconceptional Medicine, 2008,

    CrossRef

  32. 32
    Elisabeth R. Mathiesen, Peter Damm, Textbook of Diabetes and Pregnancy, 2008,

    CrossRef

  33. 33
    Aruna Natarajan, Pedro A. Jose, Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies, 2008,

    CrossRef

  34. 34
    Rebecca L Branch, Una Martin, Adverse effects of angiotensin-converting enzyme inhibitors and Angiotensin-II receptor blockers in pregnancy, Adverse Drug Reaction Bulletin, 2007, &NA;, 246, 943

    CrossRef

  35. 35
    Birna Bjarnason-Wehrens, Klaus Held, Eike Hoberg, Marthin Karoff, Bernhard Rauch, Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha), Clinical Research in Cardiology Supplements, 2007, 2, 3, 1

    CrossRef

  36. 36
    Liz Lightstone, Renal disease and pregnancy, Medicine, 2007, 35, 9, 524

    CrossRef

  37. 37
    Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2007,

    CrossRef

  38. 38
    Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2007,

    CrossRef

  39. 39
    Marianne J. Legato, Andrea Gelzer, Robin Goland, Susana A. Ebner, Sabitha Rajan, Victor Villagra, Mark Kosowski, Gender-specific care of the patient with diabetes: Review and recommendations, Gender Medicine, 2006, 3, 2, 131

    CrossRef

  40. 40
    William O. Cooper, Sonia Hernandez-Diaz, Patrick G. Arbogast, Judith A. Dudley, Shannon Dyer, Patricia S. Gideon, Kathi Hall, Wayne A. Ray, Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors, New England Journal of Medicine, 2006, 354, 23, 2443

    CrossRef

  41. 41
    Fumio Niimura, Valentina Kon, Iekuni Ichikawa, The renin???angiotensin system in the development of the congenital anomalies of the kidney and urinary tract, Current Opinion in Pediatrics, 2006, 18, 2, 161

    CrossRef

  42. 42
    Hong Lu, Curtis Klaassen, Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents, Peptides, 2006, 27, 4, 850

    CrossRef

  43. 43
    Ihor V. Yosypiv, Samir S. El-Dahr, Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system, Pediatric Nephrology, 2005, 20, 9, 1219

    CrossRef

  44. 44
    Susan Euling, Carole Kimmel, Gary Kimmel, Developmental and Reproductive Toxicology, 2005,

    CrossRef